Phase II prevention trial of celecoxib in women at increased risk for breast cancer

被引：0
|
作者：
Arun, B.
Logan, C.
Yin, G.
Yun, G.
Hortobagyi, G. G.
Browne, D.
Sneige, N.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1501
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II breast cancer chemoprevention study with celecoxib in women at increased risk for breast cancer.
    Arun, B.
    Valero, V.
    Yin, G.
    Babiera, G.
    Murray, J. L.
    Browne, D.
    Gong, Y.
    Cook, E.
    Hortobagyi, G. N.
    Sneige, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 51S - 51S
  • [2] Phase II biomarker prevention trial of celecoxib vs. placebo in women at high risk for development of breast cancer.
    Fabian, Carol
    Kimler, Bruce
    Mayo, Matthew
    Zalles, Carola
    CANCER RESEARCH, 2008, 68 (09)
  • [3] Phase II tissue-based biomarker prevention trial of celecoxib in premenopausal women at high risk for development of breast cancer.
    Fabian, C. J.
    Kimler, B. F.
    Mayo, M. S.
    Zalles, C. H.
    Khan, S. A.
    Dooley, W. C.
    Krontiras, H.
    Browne, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S179 - S179
  • [4] Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study
    Bayraktar, Soley
    Baghaki, Sema
    Wu, Jimin
    Liu, Diane D.
    Gutierrez-Barrera, Angelica M.
    Bevers, Therese B.
    Valero, Vicente
    Sneige, Nour
    Arun, Banu K.
    CANCER PREVENTION RESEARCH, 2020, 13 (09) : 795 - 802
  • [5] The GISS Trial: a Phase II Prevention Trial of Screening Plus Goserelin, Ibandronate, versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer
    von Minckwitz, Gunter
    Loibl, Sibylle
    Jackisch, Christian
    Paepke, Stefan
    Nestle-Kraemling, Caroline
    Lux, Michael P.
    Maass, Nico
    Schmutzler, Rita
    du Bois, Andreas
    Wallwiener, Diethelm
    Vescia, Sabine
    Budischewski, Kai
    Kaufmann, Manfred
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (10) : 2141 - 2149
  • [6] Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer
    Lustberg, Maryam B.
    Povoski, Stephen P.
    Zhao, Weiqiang
    Ziegler, Rebecca M.
    Sugimoto, Yasuro
    Ruppert, Amy S.
    Lehman, Amy M.
    Shiels, Donna R.
    Mrozek, Ewa
    Ramaswamy, Bhuvaneswari
    Layman, Rachel M.
    Brueggemeier, Robert W.
    Shapiro, Charles L.
    CLINICAL BREAST CANCER, 2011, 11 (04) : 221 - 227
  • [7] uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
    Qin, Wenyi
    Zhu, Weizhu
    Hewett, John E.
    Rottinghaus, George
    Chen, Yin-Chieh
    Flynn, John T.
    Kliethermes, Beth
    Mannello, Ferdinando
    Sauter, Edward R.
    BMC CANCER, 2008, 8 (1)
  • [8] uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer
    Wenyi Qin
    Weizhu Zhu
    John E Hewett
    George Rottinghaus
    Yin-Chieh Chen
    John T Flynn
    Beth Kliethermes
    Ferdinando Mannello
    Edward R Sauter
    BMC Cancer, 8
  • [9] The RAZOR trial: a phase II prevention trial of screening plus goserilin and raloxifene versus screening alone in pre-menopausal women at increased risk of breast cancer.
    Motion, J.
    Ashcroft, L.
    Dowsett, M.
    Cuzick, J.
    Hickman, J.
    Evans, G.
    Eccles, D.
    Eeles, R.
    Greenhalgh, R.
    Affen, J.
    Bundred, S.
    Boggis, C.
    Sergeant, J.
    Fallowfield, L.
    Adams, J.
    Howell, A.
    CANCER RESEARCH, 2012, 72
  • [10] Prevention of breast cancer using rexinoids: results of a phase II biomarker modulation trial using bexarotene in women at high risk of breast cancer.
    Brown, P.
    Arun, B.
    Miller, A.
    Isaacs, C.
    Gutierrez, C.
    Huang, J.
    Mohsin, S.
    Sneige, N.
    Kim, H.
    Sexton, K.
    Weiss, H.
    Hilsenbeck, S.
    Lamph, W.
    Negro-Vilar, A.
    Johnson, K.
    Elledge, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S181 - S182
12345